Scopus Biopharma Inc
SCPS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.83K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $16,834.00 |
|---|---|
| Enterprise Value | $-345,263.00 |
| Earnings per Share | $-0.55 |
| Beta | -2.01 |
| Outstanding Shares | 39,742,505 |
Return
| Return on Equity | 92.00% |
|---|---|
| Return on Assets | -1747.71% |
| Return on Invested Capital | 88.94% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.04 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-0.22
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.22
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Scopus Biopharma Inc
1 employees
Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics capitalizing on groundbreaking scientific and medical discoveries from leading research and academic institutions. The company’s lead drug cand...